Address
Other Office
1901 Olathe Boulevard
Kansas City, KS 66103
United States
Website
Industry
VCID: 2510
Profile
Corporate information
Official name
MPM Asset Management Limited Liability Company
Registration country
Investment activity status
Active investor
Investments
Selected investments
| Company | Country | Notes | ||
|---|---|---|---|---|
|
AVEO Pharmaceuticals Inc Biopharmaceutical company discovering, developing and commercializing cancer therapeutics. |
United States | N/A Active |
|
|
|
EKR Therapeutics Inc |
United States | N/A |
|
|
|
KaloBios Pharmaceuticals Inc Develops first- or best-in-class antibody therapeutics in the fields of autoimmunity |
United States | N/A |
|
|
|
Poniard Pharmaceuticals Inc Develops and commercializes oncology products. |
United States | N/A |
|
|
|
Solasia Pharma KK |
Japan | N/A |
|
|
|
Xanodyne Pharmaceuticals Inc Specialty pharmaceuticals for pain and women's health |
United States | N/A |
|
|
|
Cardiac Dimensions Inc Medical device company developing novel interventional tools for the treatment of heart failure & the related condition of mitral valve regurgitation. |
United States | N/A |
|
|
|
EnteroMedics Inc Develops therapeutic devices for the treatment of obesity. Its VSM technology uses electrical signals, delivered by an implantable electrode array, to |
United States | N/A |
|
|
|
MacroGenics Inc Biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases. |
United States | N/A Active |
|
|
|
PrimeraDx Inc Provider of Scalable Target Amplification Routine technology. |
United States | N/A |
|
|
|
Somaxon Pharmaceuticals Inc |
United States | N/A |
|
|
|
Zalicus Inc Combination drug development |
United States | N/A |
|
|
|
Portola Pharmaceuticals Inc |
United States | N/A Active |
|
|
|
Celladon Corp |
United States | N/A |
|
|
|
Epigenomics |
Germany | N/A |
|
|
|
NeoVista Inc |
United States | N/A |
|
|
|
Proteon Therapeutics Inc |
United States | N/A |
|
|
|
Syndax Pharmaceuticals Inc A clinical development company focused on novel oral therapies for cancer. |
United States | N/A Active |
|
|
|
EndoGastric Solutions Inc |
United States | N/A Initial investment. Round participant. Active |
|
|
|
Allozyne Inc |
United States | N/A Active |